Revolution Medicines, Inc. (RVMD:NASDAQ) closed at $191.31 on October 30, 2026, up 0.55% on the day. The stock trades 14.7% below its 52-week high of $224.31 and 237.6% above its 52-week low of $56.66. Over the past year, it gained 225.1%. Revolution Medicines, Inc. is part of the Health Care sector.
In 252 trading sessions since October 30, 2025, RVMD closed higher on 138 days (55%). Its best day was April 13, 2026 (+41.35%) and its worst was January 26, 2026 (-16.87%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 3 times.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
Find more stocks like RVMD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.